WTI slumps below $73.00 as traders continue to watch US-Iran peace talks
West Texas Intermediate (WTI), the US crude oil benchmark, is trading around $72.75 during the early European trading hours on Tuesday. The WTI price falls to the lowest level since early March as traders continue to watch US-Iran moves. Traders brace for the American Petroleum Institute (API) weekly crude oil report, which is due later on Tuesday.
US Vice President JD Vance said on Monday that Iran would allow nuclear inspectors to return to the country after what he called “great progress” on the first day of US-Iran negotiations in Switzerland.
Nonetheless, Iran’s Foreign Minister Abbas Araghchi said earlier that real negotiations on the "nuclear issue" haven't started yet. Washington will mediate another round of talks beginning Tuesday to end clashes in southern Lebanon between Iran-backed Hezbollah and Israel, according to a US State Department official.
Traders will closely monitor further progress in negotiations aimed at securing a lasting peace agreement between the US and Iran. Easing geopolitical tensions and a temporary US license for Iranian oil sales supported expectations of a gradual recovery in the Gulf supply flows, which weigh on the WTI price.
Also, the American Petroleum Institute (API) weekly crude oil report is due later on Tuesday. A larger-than-expected crude oil inventory draw indicates stronger demand and could lift the WTI price, while a bigger build than estimated signals weaker demand or excess supply, which might undermine the WTI price.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
